GlaxoSmithKline Plc has entered into a collaboration with Insilico Medicine Inc to use the US company’s artificial intelligence (AI) platform to discover new drugs. This is its second AI deal in less than two months. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
